Senseonics Announces the Completion of US Patient Enrollment in the PROMISE 180-Day Sensor Clinical Study
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first...